Yoshinari Uehara Selected Research

Yoshinari Uehara Research Topics

Disease

15	Atherosclerosis 01/2016 - 09/2002
11	Hypertension (High Blood Pressure) 06/2018 - 11/2007
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 01/2013
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 07/2009
5	Inflammation (Inflammations) 01/2016 - 02/2007
3	Atherosclerotic Plaque (Atheroma) 01/2017 - 01/2013
3	Reperfusion Injury 10/2016 - 02/2010
3	Ischemia 03/2016 - 04/2008
3	Myocardial Infarction 05/2015 - 01/2013
3	Hypercholesterolemia 01/2012 - 11/2007
2	Stroke (Strokes) 01/2020 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 10/2016 - 01/2016
2	Acute Coronary Syndrome 10/2016 - 02/2015
2	Diabetes Mellitus 05/2015 - 03/2011
2	Body Weight (Weight, Body) 01/2015 - 09/2002
2	Coronary Disease (Coronary Heart Disease) 01/2012 - 12/2005
2	Obesity 01/2011 - 07/2010
2	Hypertriglyceridemia 05/2007 - 05/2007
1	Rare Diseases (Rare Disease) 05/2024
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 05/2024
1	Fatty Liver 05/2024
1	Autoimmune Diseases (Autoimmune Disease) 08/2023
1	Dyslipidemias (Dyslipidemia) 06/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Headache (Headaches) 01/2020
1	Pain (Aches) 01/2020
1	Fever (Fevers) 01/2020
1	Pruritus (Itching) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Atrophy 11/2019
1	Muscular Atrophy (Muscle Atrophy) 11/2019
1	Pathologic Constriction (Stenosis) 01/2017
1	Myocardial Reperfusion Injury 10/2016
1	Infarction (Infarctions) 01/2016
1	Hyperglycemia 05/2015

Drug/Important Bio-Agent (IBA)

17	CholesterolIBA 01/2023 - 09/2002
9	HDL LipoproteinsIBA 06/2023 - 09/2007
7	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2016 - 09/2006
6	LDL CholesterolIBA 05/2024 - 09/2002
6	LipidsIBA 01/2023 - 09/2002
6	Chymases (Chymase)IBA 06/2018 - 09/2002
6	Losartan (Cozaar)FDA LinkGeneric 12/2015 - 01/2011
6	oxidized low density lipoproteinIBA 01/2013 - 12/2005
4	ApolipoproteinsIBA 05/2024 - 06/2008
4	HDL CholesterolIBA 06/2023 - 08/2010
4	Peptides (Polypeptides)IBA 03/2016 - 01/2013
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 09/2009
4	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2015 - 01/2011
3	SaltsIBA 06/2018 - 01/2011
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016 - 04/2008
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 02/2007
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 10/2014 - 03/2008
3	Angiotensin II Type 1 Receptor BlockersIBA 12/2013 - 07/2009
3	Valsartan (Vals)FDA Link 01/2013 - 07/2009
3	olmesartanIBA 01/2013 - 07/2009
3	low density lipoprotein inhibitorIBA 01/2012 - 12/2005
2	Lipoproteins (Lipoprotein)IBA 05/2024 - 03/2008
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2017 - 01/2013
2	IceIBA 01/2016 - 09/2014
2	Antihypertensive Agents (Antihypertensives)IBA 12/2015 - 07/2009
2	Messenger RNA (mRNA)IBA 01/2015 - 06/2008
2	Rosuvastatin Calcium (Crestor)FDA Link 10/2014 - 09/2009
2	Irbesartan FDA LinkGeneric 01/2013 - 01/2012
2	Telmisartan (Micardis)FDA Link 01/2013 - 09/2012
2	AdiponectinIBA 07/2011 - 03/2011
2	AntioxidantsIBA 01/2011 - 02/2010
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2009 - 04/2008
1	VitaminsIBA 05/2024
1	O(4)-methylthymidine triphosphateIBA 05/2024
1	Dietary Fats (Dietary Fat)IBA 05/2024
1	Apolipoproteins B (ApoB)IBA 05/2024
1	AutoantibodiesIBA 08/2023
1	Immunoglobulin G (IgG)IBA 08/2023
1	policosanolIBA 06/2023
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 04/2021
1	Nuclear RNAIBA 04/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Type A Botulinum Toxins (Botox)FDA Link 01/2020
1	Complementary DNA (cDNA)IBA 12/2019
1	Polymethyl Methacrylate (Sol)IBA 11/2019
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 11/2019
1	RivaroxabanIBA 10/2016
1	A-factor (Streptomyces)IBA 10/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2016
1	Drinking WaterIBA 12/2015
1	hydrochlorothiazide drug combination captoprilIBA 12/2015
1	Amlodipine (Norvasc)FDA LinkGeneric 12/2015
1	Eplerenone (Inspra)FDA LinkGeneric 12/2015

Therapy/Procedure

11	Therapeutics 01/2020 - 04/2008
2	Stents 12/2009 - 07/2009
1	Occupational Therapy (Therapy, Occupational) 01/2020
1	Transcranial Direct Current Stimulation 01/2020
1	Psychology Biofeedback (Biofeedback) 01/2019
1	Secondary Prevention 10/2016
1	Catheters 01/2016